Obducat (OBDU) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Revenue for Q1 2025 was 6.7 MSEK, down from 9.9 MSEK year-over-year, in line with internal expectations due to planned deliveries later in the year.
Order intake increased to 12.1 MSEK (7.4 MSEK), with a closing order backlog of 97.5 MSEK expected to be delivered during 2025.
Operating result was -9.4 MSEK (-5.5 MSEK), and result before tax was -13.4 MSEK (-5.0 MSEK).
Cash flow after investments was -0.2 MSEK (0.1 MSEK), with liquidity strained due to capital tied in undelivered products and bank guarantees.
A rights issue completed in April 2025 raised 35 MSEK, improving financial stability and enabling increased inventory and shorter delivery times.
Financial highlights
Revenue for Q1 2025: 6.7 MSEK (9.9 MSEK year-over-year).
Gross margin: 60% (76% year-over-year).
Operating result: -9.4 MSEK (-5.5 MSEK year-over-year).
Result before tax: -13.4 MSEK (-5.0 MSEK year-over-year).
EPS: -0.08 SEK (-0.03 SEK year-over-year).
Cash flow from operations: -9.2 MSEK (5.3 MSEK year-over-year).
Cash and cash equivalents at period end: 1.6 MSEK (1.4 MSEK year-over-year).
Outlook and guidance
Full-year 2025 revenue expected to reach approximately 104 MSEK if the current order backlog is fully delivered, excluding new sales.
Management remains confident in long-term growth, driven by structural trends in AI, defense, and electrification.
Latest events from Obducat
- Sharp revenue drop and operating loss in 2025; liquidity stabilized by rights issue in 2026.OBDU
Q4 202520 Feb 2026 - Sharp revenue drop and losses prompt new financing and strategic focus on 2026 recovery.OBDU
Q3 202514 Nov 2025 - Revenue and order intake fell significantly, with liquidity and financing risks remaining acute.OBDU
Q2 202525 Jul 2025 - Revenue up in Q3, but weak order intake and financing risks threaten ongoing operations.OBDU
Q3 202413 Jun 2025 - Revenue and margins improved in Q2, with higher order intake and a positive H2 outlook.OBDU
Q2 202413 Jun 2025 - Order intake rebounded in Q4, but full-year results were impacted by delays and financing needs.OBDU
Q4 20245 Jun 2025